Deals Search SEC Investors Sectors Insights Ask AI Signal Pricing API

Sign In Get Access

Deals Search SEC Investors Sectors Insights Ask AI Signal Pricing API

Sign In Get Access

← All investors

Venrock

1 portfolio company · $560K tracked · Public Equity (NASDAQ)

Portfolio companies

Enliven Therapeutics, Inc.

Rule 144 Public Equity (NASDAQ) · BURLINGAME, CA

Other investors

Khosla Ventures Goldman Sachs T. Rowe Price General Catalyst GV Sequoia Capital Kleiner Perkins New Enterprise Associates Accel F-Prime Capital

Deals Insights API Contact Privacy Terms Cookies

Deal intelligence from public SEC filings. Each document links to its free original. Not investment advice.